title: [Significance of vasomotor reactions for gynecologic oncologic therapy].
authors.affiliation: Inst. f. Pharmakol., Tox. u. Pharmazie, Urol. Klinik München Grosshadern.
authors.forename: E
authors.initials: E
authors.lastname: Neu
authors.forename: M C
authors.initials: MC
authors.lastname: Michailov
authors.forename: U
authors.initials: U
authors.lastname: Welscher
authors.forename: K
authors.initials: K
authors.lastname: Tempel
authors.forename: N
authors.initials: N
authors.lastname: Willich
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005833:Genital Neoplasms, Female / Q000098:blood supply / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D006979:Hyperthermia, Induced; D051381:Rats; D014661:Vasoconstriction / Q000187:drug effects / Q000528:radiation effects; D014666:Vasomotor System / Q000187:drug effects / Q000528:radiation effects*
chemical_list: D000970:Antineoplastic Agents; D001761:Bleomycin; D004317:Doxorubicin